Loomis, Sayles & Company
CNMD icon

Loomis, Sayles & Company’s CONMED CNMD Stock Holding History

Loomis, Sayles & Company’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-101,534
Closed -$6.95M – 736
2024
Q4 		$6.95M Hold
101,534
– – 0.01% 400
2024
Q3 		$7.3M Sell
101,534
-5,059
-5% -$357K 0.01% 390
2024
Q2 		$7.39M Hold
106,593
– – 0.01% 396
2024
Q1 		$8.54M Sell
106,593
-705,008
-87% -$62.8M 0.01% 370
2023
Q4 		$88.9M Buy
811,601
+22,461
+3% +$2.32M 0.14% 71
2023
Q3 		$79.6M Sell
789,140
-8,570
-1% -$985K 0.14% 72
2023
Q2 		$108M Sell
797,710
-5,353
-0.7% -$653K 0.17% 63
2023
Q1 		$83.4M Buy
803,063
+47,747
+6% +$4.62M 0.14% 73
2022
Q4 		$67M Sell
755,316
-10,734
-1% -$891K 0.13% 86
2022
Q3 		$61.4M Sell
766,050
-6,696
-0.9% -$632K 0.12% 85
2022
Q2 		$74M Sell
772,746
-2,251
-0.3% -$270K 0.14% 76
2022
Q1 		$115M Buy
774,997
+31,892
+4% +$4.45M 0.15% 64
2021
Q4 		$105M Buy
743,105
+64,632
+10% +$9.15M 0.13% 69
2021
Q3 		$88.8M Buy
678,473
+415
+0.1% +$54.3K 0.11% 80
2021
Q2 		$93.2M Buy
678,058
+32,319
+5% +$4.42M 0.11% 82
2021
Q1 		$84.3M Buy
645,739
+350,239
+119% +$42.2M 0.11% 81
2020
Q4 		$33.1M Buy
295,500
+227,218
+333% +$21.5M 0.04% 190
2020
Q3 		$5.37M Buy
+68,282
New +$5.57M 0.01% 391
2020
Q2 		– Sell
-469,068
Closed -$26.9M – 692
2020
Q1 		$26.9M Buy
469,068
+51,600
+12% +$4.76M 0.06% 126
2019
Q4 		$46.7M Sell
417,468
-1,340
-0.3% -$143K 0.08% 102
2019
Q3 		$40.3M Buy
418,808
+47,481
+13% +$4.46M 0.08% 102
2019
Q2 		$31.8M Buy
371,327
+145,670
+65% +$12M 0.06% 139
2019
Q1 		$18.8M Buy
+225,657
New +$16.4M 0.04% 214
2018
Q4 		– Sell
-113
Closed -$9K – 851
2018
Q3 		$9K Buy
+113
New +$8.74K ﹤0.01% 813

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Loomis, Sayles & Company's CNMD Position: Q1 2025 in Review

Loomis, Sayles & Company sold out of CONMED (CNMD) in Q1 2025, closing a stake of 101,534 shares — an estimated $6.95M sold.

Loomis, Sayles & Company first reported a position in CNMD in Q3 2018 and held it in 24 quarters. The position peaked at $115M in Q1 2022. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

  • Loomis, Sayles & Company reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
  • Loomis, Sayles & Company sold 101,534 CONMED shares in Q1 2025, an estimated $6.95M.
  • Loomis, Sayles & Company first reported a position in CONMED in Q3 2018 and held it in 24 quarters.
  • Loomis, Sayles & Company's CONMED position peaked at $115M in Q1 2022.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Loomis, Sayles & Company's 13F filing for Q1 2025, filed 14 May 2025.